AAV2-hCHM

AAV2-hCHM · Spark Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAV2-hCHM, covering 2023-11-02 to 2023-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations [Phase 1, Phase 2]

See pricing